Pacific Shuanglin Bio pharmacy Co Ltd (000403) — Cash Flow Reinvestment Rate
Pacific Shuanglin Bio pharmacy Co Ltd (000403) has a Cash Flow Reinvestment Rate of 1.03x as of September 2025, reinvesting CN¥72.17 Million (capex CN¥72.17 Million ) from operating cash flow of CN¥70.28 Million. Explore Pacific Shuanglin Bio pharmacy Co Ltd (000403) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pacific Shuanglin Bio pharmacy Co Ltd Cash Flow Reinvestment Rate (2000–2024)
Historical reinvestment intensity for Pacific Shuanglin Bio pharmacy Co Ltd across 21 annual periods. Also explore Pacific Shuanglin Bio pharmacy Co Ltd assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Pacific Shuanglin Bio pharmacy Co Ltd (2000–2024)
Year-by-year capital reinvestment analysis for Pacific Shuanglin Bio pharmacy Co Ltd. For live market cap and broader valuation context, see Pacific Shuanglin Bio pharmacy Co Ltd (000403) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.11x | CN¥679.47 Million | CN¥321.79 Million | CN¥520.71 Million | ▲ +115.1% |
| 2023 | 0.98x | CN¥666.48 Million | CN¥679.01 Million | CN¥377.27 Million | ▼ -18.1% |
| 2022 | 1.20x | CN¥628.64 Million | CN¥524.22 Million | CN¥378.64 Million | ▲ +1.5% |
| 2021 | 1.18x | CN¥482.46 Million | CN¥408.22 Million | CN¥326.16 Million | ▲ +17.2% |
| 2020 | 1.01x | CN¥196.48 Million | CN¥194.84 Million | CN¥40.18 Million | ▼ -2.5% |
| 2019 | 1.03x | CN¥197.41 Million | CN¥190.84 Million | CN¥41.11 Million | ▲ +201.5% |
| 2018 | 0.34x | CN¥40.02 Million | CN¥116.63 Million | CN¥35.02 Million | ▼ -91.4% |
| 2016 | 3.98x | CN¥248.83 Million | CN¥62.49 Million | CN¥98.03 Million | ▲ +334.8% |
| 2015 | 0.92x | CN¥64.39 Million | CN¥70.31 Million | CN¥59.39 Million | ▼ -0.7% |
| 2014 | 0.92x | CN¥71.05 Million | CN¥77.04 Million | CN¥71.05 Million | ▼ -48.5% |
| 2013 | 1.79x | CN¥162.99 Million | CN¥91.01 Million | CN¥162.99 Million | ▲ +22.4% |
| 2012 | 1.46x | CN¥180.28 Million | CN¥123.24 Million | CN¥180.28 Million | ▲ +158.7% |
| 2011 | 0.57x | CN¥73.58 Million | CN¥130.14 Million | CN¥73.58 Million | ▼ -84.7% |
| 2010 | 3.69x | CN¥36.46 Million | CN¥9.88 Million | CN¥36.46 Million | ▲ +487.4% |
| 2009 | 0.63x | CN¥70.29 Million | CN¥111.86 Million | CN¥70.29 Million | ▲ +8.0% |
| 2008 | 0.58x | CN¥43.59 Million | CN¥74.90 Million | CN¥43.59 Million | ▲ +776.6% |
| 2007 | 0.07x | CN¥6.31 Million | CN¥95.03 Million | CN¥6.31 Million | ▼ -53.2% |
| 2005 | 0.14x | CN¥6.95 Million | CN¥49.06 Million | CN¥6.95 Million | ▼ -74.7% |
| 2002 | 0.56x | CN¥89.09 Million | CN¥159.18 Million | CN¥89.09 Million | ▼ -29.2% |
| 2001 | 0.79x | CN¥87.96 Million | CN¥111.28 Million | CN¥87.96 Million | ▼ -61.8% |
| 2000 | 2.07x | CN¥56.62 Million | CN¥27.36 Million | CN¥56.62 Million | — |